|
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
100 Clinical Results associated with NF-κB x CFL1 x GR
100 Translational Medicine associated with NF-κB x CFL1 x GR
0 Patents (Medical) associated with NF-κB x CFL1 x GR